NEW YORK, Oct. 2, 2018 /PRNewswire/ -- Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and VaccinesRead the full report: https://www.reportlinker.com/p04974738
The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3% in the first half of the forecast period. The market is estimated at $12.2bn in 2017 and $14.3bn in 2022.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 256-page report you will receive 97 tables and 100 figures- all unavailable elsewhere.The 256-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope- Global Allergic Rhinitis Drugs Market forecasts from 2018-2028- Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2028 for the following submarkets:- Intranasal Antihistamines- Intranasal Corticosteroids- Oral Antihistamines- Immunotherapy and Vaccines- How will leading allergic rhinitis drugs perform to 2028 at world level? Our study forecasts individual revenues of these 27 products:- Patanase- Astepro- Astelin- Dymista- Nasonex- Avamys- Veramyst- Flixonase- Rhinocort- Omnaris- Nasacort- Beconase- Qnasl- Zetonna- Allegra- Zyrtec- Claritin- Xyzal- Allelock- Clarinex- Ebastel- Talion- Staloral- Alutard SQ- Grazax- Ragwitek- Generic Azelastine- This report provides individual revenue forecasts to 2028 for these regional and national markets:- US- EU5 - Germany, UK, France, Italy and Spain- China- Japan- India- Russia- Brazil- Rest of the WorldEach national market is further segmented by submarket.- Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:- GlaxoSmithKline (GSK)- Merck & Co- Sanofi- Johnson & Johnson- ALK-Abello- UCB- Kyowo Hako Kirin- Stallergenes Greer- This report discusses the trends and development in the allergic rhinitis pipeline- Our study discusses strengths, weaknesses, opportunities and threats as well as porter's five forces analysis of the global allergic rhinitis drugs marketRead the full report: https://www.reportlinker.com/p04974738
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/the-global-allergic-rhinitis-drugs-market-is-expected-to-grow-at-a-cagr-of-3-3-300722884.html
SOURCE Reportlinker
